CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Clinical trials for CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to fight skin cancer in transplant patients
Disease control TerminatedThis study was designed to test a drug called tolododekin alfa (ANK-101) given before surgery to kidney transplant recipients with high-risk skin cancer. The goal was to see if the drug could reduce the number of cancer cells in the removed tissue. However, the trial was withdraw…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Phase: PHASE1 • Sponsor: Ankyra Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope: expanded access to cemiplimab for cancer patients
Disease control APPROVED_FOR_MARKETINGThis program provides expanded access to cemiplimab, an immunotherapy drug, for patients with certain solid tumors including non-small cell lung cancer, basal cell carcinoma, and cutaneous squamous cell carcinoma. The goal is to make the treatment available to those who may not h…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a simple blood test predict skin cancer outcomes?
Knowledge-focused OngoingThis study looks at blood samples from 20 adults with melanoma or other skin cancers to see if certain markers in the blood can predict how well treatment works or how long someone lives. Researchers will compare these markers to standard measures like tumor response and survival…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC